Trial
NCT02706691
BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Chicago
Collaborators
Novartis
Condition
FGFR Gene Amplification
Intervention
BGJ398
Why stopped
Study stopped due to poor enrollment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-04-16